New hope for septic shock: small trial tests potential Life-Saving drug combo
NCT ID NCT07451886
Summary
This small pilot study aims to see if adding a drug called fludrocortisone to standard treatment helps patients survive septic shock, a deadly condition where infection causes dangerously low blood pressure. The study will involve 32 critically ill patients in intensive care units across three countries. The main goal is to determine if a much larger international trial testing this combination therapy is practical to conduct.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
North District Hospital
Hong Kong, Hong Kong
-
Pamela Youde Nethersole Hospital
Hong Kong, Hong Kong
-
Prince of Wales Hospital
Hong Kong, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Princess Margaret Hospital
Hong Kong, Hong Kong
-
Queen Mary Hospital
Hong Kong, Hong Kong
Conditions
Explore the condition pages connected to this study.